These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25751765)

  • 41. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D
    Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG; Marshall JS
    J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal adjuvants.
    Stevceva L; Ferrari MG
    Curr Pharm Des; 2005; 11(6):801-11. PubMed ID: 15777234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration.
    von Beust BR; Johansen P; Smith KA; Bot A; Storni T; Kündig TM
    Eur J Immunol; 2005 Jun; 35(6):1869-76. PubMed ID: 15909311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
    Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
    Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection.
    Lv S; Wang J; Dou S; Yang X; Ni X; Sun R; Tian Z; Wei H
    Hepatology; 2014 Feb; 59(2):385-94. PubMed ID: 23907803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
    Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
    Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
    Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
    Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CpG ODN nanorings induce IFNα from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity.
    Gungor B; Yagci FC; Tincer G; Bayyurt B; Alpdundar E; Yildiz S; Ozcan M; Gursel I; Gursel M
    Sci Transl Med; 2014 May; 6(235):235ra61. PubMed ID: 24807558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments.
    Suzuki F; Maeyama JI; Kubota A; Nishimune A; Horiguchi S; Takii T; Urasaki Y; Shimada I; Iho S
    Vaccine; 2023 Feb; 41(8):1447-1456. PubMed ID: 36702691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
    Fukuiwa T; Sekine S; Kobayashi R; Suzuki H; Kataoka K; Gilbert RS; Kurono Y; Boyaka PN; Krieg AM; McGhee JR; Fujihashi K
    Vaccine; 2008 Sep; 26(37):4849-59. PubMed ID: 18625280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.
    Hanagata N
    Int J Nanomedicine; 2017; 12():515-531. PubMed ID: 28144136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.
    Xue G; Yu L; Li S; Shen X
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns.
    De Wit D; Olislagers V; Goriely S; Vermeulen F; Wagner H; Goldman M; Willems F
    Blood; 2004 Feb; 103(3):1030-2. PubMed ID: 14504106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells.
    Hurtado P; Peh CA
    J Immunol; 2010 Feb; 184(3):1425-35. PubMed ID: 20042575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N6-methylated adenine on the target sites of mamA from Mycobacterium bovis BCG enhances macrophage activation by CpG DNA in mice.
    Tsukamoto Y; Tamura T; Maeda Y; Miyake K; Ato M
    Tuberculosis (Edinb); 2020 Mar; 121():101890. PubMed ID: 32279869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.
    Gupta GK; Agrawal DK
    BioDrugs; 2010 Aug; 24(4):225-35. PubMed ID: 20623989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.